×
About 3,297 results

ALLMedicine™ Chronic Urticaria Center

Research & Reviews  1,181 results

The global burden of chronic urticaria for the patient and society.
https://doi.org/10.1111/bjd.19561
The British Journal of Dermatology; Gonçalo M, Gimenéz-Arnau A et. al.

Sep 21st, 2020 - Chronic urticaria (CU) affects about 1% of the world population of all ages, mostly young/middle-aged females, usually lasts for several years (>1 year in 25-75% of patients), and often takes >1 year before effective management is implemented. It ...

Efficacy of omalizumab treatment for pediatric chronic spontaneous urticaria: A multi-c...
https://doi.org/10.1111/pde.14360
Pediatric Dermatology REFERENCES; Ari A, Levy Y et. al.

Sep 20th, 2020 - Chronic urticaria is defined by the presence of itchy wheals, sometimes accompanied by angioedema, lasting for at least 6 weeks. In children, most cases occur without an eliciting factor and are defined as chronic spontaneous urticaria (CSU). CSU ...

The Chronic Urticaria Registry (CURE):Rationale, Methods, and Initial Implementation.
https://doi.org/10.1111/jdv.16947
Journal of the European Academy of Dermatology and Venereology : JEADV; Weller K, Giménez-Arnau A et. al.

Sep 18th, 2020 - Chronic urticaria (CU) is a common disease, characterized by the recurrent appearance of wheals, angioedema, or both for more than 6 weeks. Its underlying biology is not well understood, and many patients do not obtain sufficient relief from recom...

Peptic Ulcer Disease is Associated with Increased Risk of Chronic Urticaria Independent...
https://doi.org/10.1007/s40257-020-00561-9
American Journal of Clinical Dermatology; Chen CM, Huang WT et. al.

Sep 11th, 2020 - Some studies showed patients with chronic urticaria have a higher rate of peptic ulcer disease (PUD). Whether PUD is a risk factor for chronic urticaria is unclear. The objective of this study was to evaluate the incidence of and risk factors for ...

Omalizumab in severe chronic urticaria: are slow and non-responders different?
https://doi.org/10.23822/EurAnnACI.1764-1489.167
European Annals of Allergy and Clinical Immunology; Asero R

Sep 11th, 2020 - Background. The response to Omalizumab by patients with severe Chronic Spontaneous Urticaria (CSU), may be rapid, slow, or absent. An early response has been associated with an IgE-mediated auto-allergic pathogenic mechanism, whereas little is kno...

see more →

Guidelines  3 results

BSACI guideline for the management of chronic urticaria and angioedema.
https://doi.org/10.1111/cea.12494
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology; Powell RJ, Leech SC et. al.

Feb 25th, 2015 - This guidance for the management of patients with chronic urticaria and angioedema has been prepared by the Standards of Care Committee of the British Society for Allergy and Clinical Immunology (BSACI). The guideline is based on evidence as well ...

The diagnosis and management of acute and chronic urticaria: 2014 update
https://www.aaaai.org/Aaaai/media/MediaLibrary/PDF%20Documents/Practice%20and%20Parameters/Urticaria-2014.pdf
Bernstein, J.

Apr 30th, 2014 - Theworkgroup was formed by the JTFPP to develop a practiceparameter to address the diagnosis and treatment of urticaria withor without angioedema. The chair, Jonathan Bernstein, MD,invited workgroup members to participate in the parameterdevelopme.

AAITO Position paper. Chronic urticaria: diagnostic workup and treatment.
https://www.ncbi.nlm.nih.gov/pubmed/18236998
European Annals of Allergy and Clinical Immunology; Tedeschi A, Girolomoni G et. al.

Feb 1st, 2008 - AAITO Position paper. Chronic urticaria: diagnostic workup and treatment.|2008|Tedeschi A,Girolomoni G,Asero R, ,|complications,therapeutic use,therapeutic use,therapeutic use,diagnosis,epidemiology,etiology,physiopathology,therapy,

see more →

Drugs  439 results see all →

Clinicaltrials.gov  1,629 results

The global burden of chronic urticaria for the patient and society.
https://doi.org/10.1111/bjd.19561
The British Journal of Dermatology; Gonçalo M, Gimenéz-Arnau A et. al.

Sep 21st, 2020 - Chronic urticaria (CU) affects about 1% of the world population of all ages, mostly young/middle-aged females, usually lasts for several years (>1 year in 25-75% of patients), and often takes >1 year before effective management is implemented. It ...

Efficacy of omalizumab treatment for pediatric chronic spontaneous urticaria: A multi-c...
https://doi.org/10.1111/pde.14360
Pediatric Dermatology REFERENCES; Ari A, Levy Y et. al.

Sep 20th, 2020 - Chronic urticaria is defined by the presence of itchy wheals, sometimes accompanied by angioedema, lasting for at least 6 weeks. In children, most cases occur without an eliciting factor and are defined as chronic spontaneous urticaria (CSU). CSU ...

Hydroxyzine hydrochloride - hydroxyzine hydrochloride tablet-REMEDYREPACK INC.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bb4a7d22-2f42-4e9f-bf98-cee43ed14d50

Sep 20th, 2020 - For symptomatic relief of anxiety and tension associated with psychoneurosis and as an adjunct in organic disease states in which anxiety is manifested. Useful in the management of pruritus due to allergic conditions such as chronic urticaria and ...

The Chronic Urticaria Registry (CURE):Rationale, Methods, and Initial Implementation.
https://doi.org/10.1111/jdv.16947
Journal of the European Academy of Dermatology and Venereology : JEADV; Weller K, Giménez-Arnau A et. al.

Sep 18th, 2020 - Chronic urticaria (CU) is a common disease, characterized by the recurrent appearance of wheals, angioedema, or both for more than 6 weeks. Its underlying biology is not well understood, and many patients do not obtain sufficient relief from recom...

Peptic Ulcer Disease is Associated with Increased Risk of Chronic Urticaria Independent...
https://doi.org/10.1007/s40257-020-00561-9
American Journal of Clinical Dermatology; Chen CM, Huang WT et. al.

Sep 11th, 2020 - Some studies showed patients with chronic urticaria have a higher rate of peptic ulcer disease (PUD). Whether PUD is a risk factor for chronic urticaria is unclear. The objective of this study was to evaluate the incidence of and risk factors for ...

see more →

News  45 results

Chronic urticaria population identified
https://www.mdedge.com/dermatology/article/199593/urticaria/chronic-urticaria-population-identified?channel=310
Richard Franki

Apr 25th, 2019 - Half a million people. That’s pretty close to the population of Sacramento.

Ligelizumab maintains urticaria control for up to 1 year
https://www.mdedge.com/dermatology/article/198549/urticaria/ligelizumab-maintains-urticaria-control-1-year?channel=310
Michele G. Sullivan

Apr 9th, 2019 - WASHINGTON – Patients with spontaneous chronic urticaria treated with the investigational anti-IgE monoclonal antibody ligelizumab experienced up to a year of symptom control in an open-label extension study, Diane Baker, MD, said at the annual me.

Choose your steps for treating chronic spontaneous urticaria
https://www.mdedge.com/dermatology/article/192975/urticaria/choose-your-steps-treating-chronic-spontaneous-urticaria
Kari Oakes

Jan 18th, 2019 - GRAND CAYMAN, CAYMAN ISLANDS – Large doses of nonsedating second-generation antihistamines are at the heart of treating chronic urticaria and will adequately control symptoms in about half of patients. Michele G.

Omalizumab for chronic urticaria quells suffocation fears
https://www.mdedge.com/dermatology/article/155758/urticaria/omalizumab-chronic-urticaria-quells-suffocation-fears
Bruce Jancin

Jan 8th, 2018 - GENEVA – Omalizumab for treatment of chronic spontaneous urticaria brings about a profound improvement in angioedema-related quality of life, a widely underappreciated dimension of the impairment caused by this disease, Karsten Weller, MD, said at.

Updosing omalizumab for chronic urticaria pays off
https://www.mdedge.com/familymedicine/article/155732/urticaria/updosing-omalizumab-chronic-urticaria-pays
Dermatology News; Bruce Jancin

Jan 8th, 2018 - GENEVA – In real-world clinical practice, roughly two-thirds of patients with chronic spontaneous urticaria treated with the approved dose of omalizumab will achieve good disease control – and for those who don’t, three-quarters will respond upon.

see more →